Horiba Acquiresa Medtesta Dxa And Pointe Scientific To Expand Laboratory Chemistry Offeringsa 02 03 2021Aa A A Press Releasehoribaltd Headquarters In Kyotojapanreferred To As Horibaand Horiba Instrumentsheadquarters In Irvinecaliforniausaannounced Today That It Has Acquireda Medtesta Holdingsinc Headquarters In Cantonmiusacomposed Ofa Medtesta Dxinc Pointe Scientificinca Clinitoxa Diagnostixinc And Medical Laboratory Solutionsinc A A The Acquisition Will Combine The Complementary Innovative Technology Offerings Of The Horiba Medical Segmentreferred To As Horiba Medicalwitha Medtesta Dxa Technology A Clinitoxand Pointe Scientific S R&D And Manufacturing Capabilitieswitha Particular Expertisea In Fda 510K And Clia Clearancesto Address The Multidisciplinary Requirements Of Ivda Testing Customers A A Oura Long Terma Vision And Continuous Investments Coupled With Our Outstanding Employees Have Resulted In Pursuing Innovative Chemistry And Immunochemistry Technology Solutionsi Am Extremely Pleased That Thisa Long Terma Vision Has Resulted In Acquiringa Medtest Said Mratsushi Horibachairman & Group Ceo Of Horibaltd A Athis Acquisition Provides Horiba Medical The Opportunity To Address The Ivd Market S Multidisciplinary Requirements Along With The Complementary Innovative Technology Of Pointe Scientific Anda Medtest Sa High Quality Chemistry Solutionshoriba Medical Will Continue Offering Innovative Technology Solutions Through Itsa Yumizena Brand And Current Distribution Channels Said Horiba Medical Segment Leader Drjaia Hakhuchairman And Ceo Of Horiba Instruments Incorporated And President Of Horiba Abx Sas In France A A Horiba Medical Will Continue Investing In Innovative Technologies For Future Ivd Requirements A A
